Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Regulatory Affairs Market , by Region, 2019-2027 (USD Billion)
1.2.2. Regulatory Affairs Market , by Service, 2019-2027 (USD Billion)
1.2.3. Regulatory Affairs Market , by Category , 2019-2027 (USD Billion)
1.2.4. Regulatory Affairs Market , by Indication, 2019-2027 (USD Billion)
1.2.5. Regulatory Affairs Market , by Product stage, 2019-2027 (USD Billion)
1.2.6. Regulatory Affairs Market , by End Use, 2019-2027 (USD Billion)
1.2.7. Regulatory Affairs Market , by company size, 2019-2027 (USD Billion)
1.2.8.
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Regulatory Affairs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Regulatory Affairs Market Dynamics
3.1. Regulatory Affairs Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Demand for faster approval process for breakthrough drugs and devices
3.1.1.2. Growth in emerging areas such as personalized medicine, biosimilars, and orphan drugs
3.1.2. Market Restraint
3.1.2.1. Risk associated with data security
3.1.2.2. Monitoring issues and lack of standardization
3.1.3. Market Opportunities
3.1.3.1. Life science companies focusing on their core competencies
3.1.3.2. Economic and competitive pressures
Chapter 4. Global Regulatory Affairs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Regulatory Affairs Market , by Service
5.1. Market Snapshot
5.2. Global Regulatory Affairs Market by Service, Performance - Potential Analysis
5.3. Global Regulatory Affairs Market Estimates & Forecasts by Service 2018-2027 (USD Billion)
5.4. Regulatory Affairs Market , Sub Segment Analysis
5.4.1. Regulatory consulting
5.4.2. Legal representation
5.4.3. Regulatory writing & publishing
5.4.4. Product registration & clinical trial applications
5.4.5. Other services
Chapter 6. Global Regulatory Affairs Market , by Category
a. Market Snapshot
6.1. Global Regulatory Affairs Market by Category, Performance - Potential Analysis
6.2. Global Regulatory Affairs Market Estimates & Forecasts by Category 2018-2027 (USD Billion)
6.3. Regulatory Affairs Market , Sub Segment Analysis
6.3.1. Drugs
6.3.2. Biologics
6.3.3. Medical Devices
Chapter 7. Global Regulatory Affairs Market , by Indication
b. Market Snapshot
7.1. Global Regulatory Affairs Market by Indication, Performance - Potential Analysis
7.2. Global Regulatory Affairs Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
7.3. Regulatory Affairs Market , Sub Segment Analysis
7.3.1. Oncology
7.3.2. Neurology
7.3.3. Cardiology
7.3.4. Immunology
7.3.5. Other Indications
Chapter 8. Global Regulatory Affairs Market , by Product stage
c. Market Snapshot
8.1. Global Regulatory Affairs Market by Product stage, Performance - Potential Analysis
8.2. Global Regulatory Affairs Market Estimates & Forecasts by product stage 2018-2027 (USD Billion)
8.3. Regulatory Affairs Market , Sub Segment Analysis
8.3.1. Preclinical
8.3.2. Clinical
8.3.3. PMA
Chapter 9. Global Regulatory Affairs Market , by End use
d. Market Snapshot
9.1. Global Regulatory Affairs Market by Product stage, Performance - Potential Analysis
9.2. Global Regulatory Affairs Market Estimates & Forecasts by product stage 2018-2027 (USD Billion)
9.3. Regulatory Affairs Market , Sub Segment Analysis
9.3.1. Medical Device Companies
9.3.2. Biotechnology Companies
9.3.3. Pharmaceutical Companies
Chapter 10. Global Regulatory Affairs Market , by Company size
e. Market Snapshot
10.1. Global Regulatory Affairs Market by Product stage, Performance - Potential Analysis
10.2. Global Regulatory Affairs Market Estimates & Forecasts by product stage 2018-2027 (USD Billion)
10.3. Regulatory Affairs Market , Sub Segment Analysis
10.3.1. Small
10.3.2. Medium
10.3.3. Large
Pharmaceutical Companies
Chapter 11. Global Regulatory Affairs Market , Regional Analysis
11.1. Regulatory Affairs Market , Regional Market Snapshot
11.2. North America Regulatory Affairs Market
11.2.1. U.S. Regulatory Affairs Market
11.2.1.1. Service breakdown estimates & forecasts, 2018-2027
11.2.1.2. Category breakdown estimates & forecasts, 2018-2027
11.2.1.3. Indication breakdown estimates & forecasts, 2018-2027
11.2.1.4. Product stage breakdown estimates & forecasts, 2018-2027 (USD Billion)
11.2.1.5. End Use breakdown estimates & forecasts, 2018-2027 (USD Billion)
11.2.1.6. Company Size breakdown estimates & forecasts, 2018-2027 (USD Billion)
11.2.2. Canada Regulatory Affairs Market
11.3. Europe Regulatory Affairs Market Snapshot
11.3.1. U.K. Regulatory Affairs Market
11.3.2. Germany Regulatory Affairs Market
11.3.3. France Regulatory Affairs Market
11.3.4. Spain Regulatory Affairs Market
11.3.5. Italy Regulatory Affairs Market
11.3.6. Rest of Europe Regulatory Affairs Market
11.4. Asia-Pacific Regulatory Affairs Market Snapshot
11.4.1. China Regulatory Affairs Market
11.4.2. India Regulatory Affairs Market
11.4.3. Japan Regulatory Affairs Market
11.4.4. Australia Regulatory Affairs Market
11.4.5. South Korea Regulatory Affairs Market
11.4.6. Rest of Asia Pacific Regulatory Affairs Market
11.5. Latin America Regulatory Affairs Market Snapshot
11.5.1. Brazil Regulatory Affairs Market
11.5.2. Mexico Regulatory Affairs Market
11.6. Rest of The World Regulatory Affairs Market
Chapter 12. Competitive Intelligence
12.1. Top Market Strategies
12.2. Company Profiles
12.2.1. Accell Clinical Research, LLC.
12.2.1.1. Key Information
12.2.1.2. Overview
12.2.1.3. Financial (Subject to Data Availability)
12.2.1.4. Product Summary
12.2.1.5. Recent Developments
12.2.2. GenPact Ltd.
12.2.3. Criterium, Inc.
12.2.4. PRA Health Sciences
12.2.5. Promedica International
12.2.6. WuXi AppTec, Inc.
12.2.7. Medpace
12.2.8. Charles River Laboratories International, Inc.
12.2.9. ICON plc
12.2.10. Covance

Chapter 13. Research Process
13.1. Research Process
13.1.1. Data Mining
13.1.2. Analysis
13.1.3. Market Estimation
13.1.4. Validation
13.1.5. Publishing
13.2. Research Attributes
13.3. Research Assumption